Company / Gross Profit per Share
Nuo Therapeutics, Inc. Gross Profit per Share History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
-$0.04
FY2017
5-year range
-$0.04 / $0.03
FY2013-FY2017
Trend
-1725.5%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share changed -1725% YoY in FY2017, a notable deviation from the 6-year average annual change of -293%.
Based on SEC 10-K filings.
-0.04 in FY2017.
Declined from $0.03 to $-0.04 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, gross profit per share decreased 1725.5% year-over-year.
- Peak gross profit per share was recorded in FY2012.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$0.04 | -1725.5% |
| FY2016 | -$0.00 | -107.2% |
| FY2015 | $0.03 | +204.9% |
| FY2014 | $0.01 | -72.2% |
| FY2013 | $0.03 | -72.2% |
| FY2012 | $0.12 | +16.8% |
| FY2011 | $0.10 | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026